# Specific Biologics funding rounds and investors

As of 2 Nov 2026, Specific Biologics has raised $35M across 1 verified round on record; latest: US$35 million Series A led by Hatteras Venture Partners, announced 2 Nov 2026.

A biotechnology company pioneering a new generation of precision gene-editing therapies for serious genetic diseases

Website: https://specificbiologics.com  
Headquarters: Toronto, Canada  
Page: https://fireround.dev/companies/specific-biologics

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-11-02 | Series A | US$35 million | Hatteras Venture Partners | adMare BioInnovations, DeepWork Capital, Genesys Capital, Life Sciences Partners, Lumira Ventures, Seido Capital | [prnewswire.com](https://www.prnewswire.com/news-releases/specific-biologics-announces-oversubscribed-us35-million-series-a-financing-to-advance-gene-editing-therapy-for-als-302926076.html), [aol.com](https://www.aol.com/articles/specific-biologics-announces-oversubscribed-us-150000000.html), [finsmes.com](https://www.finsmes.com/2026/11/specific-biologics-raises-35m-in-series-a-funding.html) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.